Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03589716 · ClinicalTrials.gov registry record · NA
Evaluating the Accuracy of an Integrated Vital Sign Measurement Platform
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 265
- Enrollment target
NCT03589716: Completed NA study, sponsored by Massachusetts General Hospital.
NCT03589716 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 265 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03589716, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 265 participants
- Enrollment target
Study Summary
Partners Connected Health will conduct a clinical validation study to evaluate the accuracy of measurement for each vital sign with the Vital Moto Mod platform, compared to appropriate reference devices used in the hospital setting. The study will recruit volunteers from the Partners Healthcare network of clinics and hospitals and the general public.
Interventions
- OTHER Vital Moto Mod
- OTHER Welch Allyn Connex Spot Vital Signs Monitor
- OTHER Capnostream 20 Portable Bedside Capnograph
- OTHER Welch Allyn 767 Mobile Aneroid Sphygmomanometerand 3M Littmann Master Classic II Teaching Stethoscope
- OTHER Scifit 1000R cycle ergometer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 265 participants |
| Start Date | 2018-07-23 |
| Est. Completion | 2019-12-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03589716
The ClinicalTrials.gov registry entry for NCT03589716 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 265 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Vital Moto Mod is the first listed.
NCT03589716 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03589716 about?
NCT03589716 is a clinical study titled "Evaluating the Accuracy of an Integrated Vital Sign Measurement Platform". Partners Connected Health will conduct a clinical validation study to evaluate the accuracy of measurement for each vital sign with the Vital Moto Mod platform, compared to appropriate reference devices used in the hospital setting. The study will recruit volunteers from the Partners Healthcare netw...
What is the current status of trial NCT03589716?
This trial is currently completed. It is a NA study. The enrollment target is 265 participants. The study started on 2018-07-23. Estimated completion is 2019-12-30.
What interventions are being tested in trial NCT03589716?
The interventions under investigation include: Vital Moto Mod (OTHER), Welch Allyn Connex Spot Vital Signs Monitor (OTHER), Capnostream 20 Portable Bedside Capnograph (OTHER), Welch Allyn 767 Mobile Aneroid Sphygmomanometerand 3M Littmann Master Classic II Teaching Stethoscope (OTHER), Scifit 1000R cycle ergometer (OTHER).
Who is sponsoring clinical trial NCT03589716?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.